Optimizing end-stage renal disease therapy for the patient with diabetes mellitus

Seminars in Nephrology

Volumn 17, Issue 4, 1997, Pages 331-345

  Friedlander, Miriam A ^a   Hricik, Donald E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEMODIALYSIS; HYPERGLYCEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALNUTRITION; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; TREATMENT PLANNING; UNITED STATES; UREMIA;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; UNITED STATES;

EID: 0030797342     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (108)

1. Friedman E: Management choices in diabetic end-stage renal disease. Nephrol Dial Transplant 10:61-79, 1995 (suppl 7)
2. Harris M: Diabetes in America. National Diabetes Data Group. Bethesda, Maryland: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995
3. Friedman E: Diabetic Nephropathy in Blacks. Transplant Proceed 25:2431-2432, 1993
4. Stephens G, Gillaspy J, Clyne D, et al: Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis 15:562-567, 1990
5. Held P, Port F, Webb R, et al: Excerpts from United States Renal Data System 1996 Annual Data Report. Am J Kidney Dis 28:sl-sl65, 1996 (suppl 2)
6. Ghavamian M, Gutch C, Kopp K, et al: The sad truth about hemodialysis in diabetic nephropathy. J Am Med Assoc 222:1386-1389, 1972
7. Blagg C, Eschback J, Sawyer T, et al: Dialysis for end stage diabetic nephropathy. Proc Clin Dial Transplant Forum 1:133-135, 1971
8. Suzuki Y, Arakawa M, Geyjo F, et al: The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Nephrol Dial Transplant 10:47-55, 1995 (suppl 7)
9. USRDS Annual Data Report. Bethesda, Maryland: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1992
10. Mattern W, McGaghie W, Rigby R, et al: Selection of ESRD Treatment: An International Study. Am J Kidney Dis 13:457-464, 1989
11. Louder G, Perri N, Friedman E: Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J Diabetes Complications 2:218-226, 1988
12. Amair P, Khanna R, Leibel B, et al: Continuous ambulatory peritoneal dialysis in diabetics with end stage renal disease. N Engl J Med 306:625-630, 1982
13. Maioroca R, Vonehs E, Cavalli P, et al: A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Pent Dial Int 11:118-127, 1991
14. Held P, Port F, Turenne M, et al: Continuous ambulatory peritoneal dialysis and hemodialysis: A comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 45:1164-1169, 1994
15. Bloemberger W, Port F, Mauger E, et al: A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6:177-183, 1995
16. Julius M, Hawthorne V, Carpentier-Alting P, et al: Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis 13:61-69, 1989
17. Rubin J, Hsu H: Continuous ambulatory peritoneal dialysis: Ten years at one facility. Am J Kidney Dis 17:165169, 1991
18. Legrain M, Rottemburg J, De Groc F, et al: Selecting the best uremia therapy, in Friedman E (ed): Diabetic Renal Retinal Syndrome. New York, NY, Grune & Stratton, 1986, pp 453-468
19. Hill M, Grossman R, Feldman H, et al: Changes in the causes of death after renal transplantation, 1966 to 1987.
20. Am J Kidney Dis 17:512-518, 1991
21. Sumrani N, Delaney V, Hong J, et al: Racial differences in renal transplant outcome of insulin-dependent diabetic recipients in the cyclosporine era. Trans Am Soc Artif Intern Organs 37:M304-M305, 1991
22. Sumrani N, Delanye V, Ding Z: Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors. Transplantation 51:343-347, 1991
23. Takemoto S, Terasaki P: A comparison of kidney transplant survival in white and black recipients. Transplant Proc 21:3865-3868, 1989
24. Opelz G, Pharr E, Englemann A, et al: Kidney graft survival rates in black cyclosporine-treated recipients: collaborative transplant study. Transplant Proc 21:3918-3920, 1989
25. Eisenbarth G: Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
26. Kennedy W, Navarro X, Goetz F: Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322:1031-1037, 1990
27. Najarian J, Canafax D, Sutherland D: Renal transplantation in diabetic patients is confirmed therapy while pancreas transplantation should be performed only in an investigational setting. J Diabetes Complications 2:158-161, 1988
28. Ramsay R, Goetz F, Sutherland D, et al: Progression of diabetic retinopathy after pancreas transplantation for insulindependent diabetes mellitus. N Engl J Med 318:208-214, 1988
29. Sutherland D, Dunn D, Goetz F: A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 210:274-285, 1989
30. Manske C, Wang Y, Thomas W: Mortality of cadav-eric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 346:1658-1662, 1995
31. Remuzzi G, Ruggenenti P, Mauer S: Pancreas and kidney/pancreas transplants: Experimental medicine or real improvement? Lancet 343:27-31, 1994
32. Cheung A, Matas A, Gruessner R, et al: Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant? Transplant Proc 25:1184-1185, 1993
33. Schulak J, Mayes J, Hricik D: Kidney transplantation in diabetic patients undergoing combined kidney-pancreas or kidney-only transplantation. Transplantation 53:685-687, 1992
34. Douzdjian V, Rice J, Gugliuzza K, et al: Renal allograft and patient outcome after transplantation: Pancreas-kidney versus kidney-alone transplants in type I diabetic patients versus kidney-alone transplants in nondiabetic patients. Am J Kidney Dis 27:106-116, 1996
35. Held PJ, Port FK, Gaylin DS, et al: The United States Renal Data System's 1992 Annual Data Report: VIII. Simultaneous kidney-pancreas transplantation versus kidney transplantation alone: Patient survival, kidney graft survival, and post-transplant hospitalization. Am J Kidney Dis 20:61-67, 1992 (suppl 2)
36. Collins A, Ma J, Urnen A, et al: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23:272-282, 1994
37. Lin J-J, Wadwha N, Suh H, et al: Increased peritoneal solute transport in diabetic peritoneal dialysis patients. Adv Pe rit Dial 11:63-66, 1995
38. Weinrauch L, D'Eliz J, Gleason R, et al: Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 70:300-303, 1992
39. Miles A, Friedman E: Dialytic therapy for diabetic patients with terminal renal failure. Curr Opin Nephrol Hypertension 2:868-875, 1993
40. Abraham P, Opsahl J, Keshaviah P, et al: Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis 16:438-446, 1990
41. Bennett W, Porter G: Cyclosporine-associated hypertension. Am J Med 85:131-133, 1988 (editorial)
42. Kasiske B: Possible causes and consequences of hypertension in stable renal transplant patients. Transplantation 44:639-643, 1987
43. Cosio F, Dillon J, Falkenhain M, et al: Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 47:1136-1141, 1995
44. Schmitz O: Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure. Dan Med Bull 38:36-52, 1991
45. Eidemak I, Feldt-Rasmussen B, Kanstrup I, et al: Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38:565-572, 1995
46. Ifudu O, Dulin A, et al: Intradialytic weight gain corre-lates with glycosylated hemoglobin in diabetic hemodialysis patients. Am J Kidney Dis 23:686-691, 1994
47. Tzamaloukas A, Oreopoulos D: Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: A Review. Adv Perit Dial 7:81-86, 1991
48. Boudreaux J, McHugh L, Canafax D, et al: The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 44:376-381, 1987
49. Yoshimura N, Nakai I, Ohmori Y, et al: Effect of cyclospirine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 12:11-17, 1988
50. Hricik D, Bartucci M, Moir E, et al: Effects of steroid withdrawal on post transplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51:374-377, 1991..
51. Newell K, Bruce D, Cronin D: Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. Transplantation 62:1353-1374, 1996
52. Smith J, Hunsicker L, Yuh W, et al: Appearance of type II diabetes mellitus in type I diabetic recipients of pancreas allografts. Transplantation 47:304-311, 1989
53. Ikizler T, Hakim R: Nutrition in end-stage renal disease. Kidney Int 50:343-357, 1995
54. Hakim R, Levin N: Malnutrition in hemodialysis patients. Am J Kidney Dis 21:125-137, 1993
55. Spiegel D, Breyer J: Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kidney Dis 23:283-285, 1994
56. Miller D, Levine S, Bristrian B, et al: Diagnosis of protein calorie malnutrition in diabetic patients on hemodialysis and peritoneal dialysis. Nephron 33:127-132, 1983
57. Foulks C, Goldstein D, Kelly M, et al: Indications for the use of intradialystic parenteral nutrition in the malnourished hemodialysis patient. J Renal Nutr 13:23-33, 1991
58. Kopple J, Bernard D, Messana J, et al: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 47:1148-1157, 1995
59. Appel G: Lipid abnormalities in renal disease. Kidney Int 39:169-183, 1991
60. Avram M, Goldwasser P, Burrell D, et al: The uremie dyslipidemia: A cross-sectional and longitudinal study. Am J Kidney Dis 20:324-335, 1992
61. Grundy S: Management of hyperlipidemia of kidney disease. Kidney Int 37:847-853, 1990
62. Eschbach J: The future of r-HuEPO. Nephrol Dial Transplant 10:96-109, 1995
63. Nissenson A: National Cooperative rHu Erythropoietin study in patients with chronic renal failure: A phase IV multicenter study. Am J Kidney Dis 4:24-33, 1991 (suppl 1)
64. Evans R: Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: A comparative analysis. Am J Kidney Dis 19:62-70, 1991 (suppl 1)
65. Ifudu O, Paul H, Mayers J, et al: Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 23:394-400, 1994
66. Ifudu O, Feldman J, Friedman E: The intensity of hemodialysis and the response to erythropoietin in patients with end stage renal disease. N Engl J Med 334:420-425, 1996
67. Harnett J, Kent G, Foley R, et al: Cardiac function and hematocrit level. Am J Kidney Dis 25:s3-7, 1995 (suppl 1)
68. Sun C, Ward H, Paul W, et al: Serum erythropoietin levels after renal transplantation. N Engl J Med 321:151-157, 1989
69. Rinehart A, Herzog C, Collins A, et al: A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25:281-290, 1995
70. Koyanagi T, Nishida H, Kitamura M, et al: Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 61:1793-1796, 1996
71. Manske C, Wang Y, Rector T, et al: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
72. Windus D, Jendrisak M, Delmez J: Prosthetic fistula survival and complications, in hemodialysis patients: effect of diabetes and age. Am J Kidney Dis 19:448-452, 1992
73. Legrain M, Rottemburg J, Bentchikou A, et al: Dialysis treatment of insulin-dependent diabetic patients: the years experience. Clin Nephrol 21:72-81, 1984
74. Rausher H, Rausher S, Friedman E: Preserving feet in the uremie diabetic: The physician's role. J Diabetes Complications 2:145-149, 1988
75. Khauli R, Novick A, Steinmuller D, et al: Comparison of renal transplantation and dialysis in rehabilitation of diabetic end stage renal disease patients. Urology 27:521-525, 1986
76. Milutinovic J, Babb A, Eschbach J, et al: Uremic neuropathy: Evidence of middle molecule toxicity. Artif Organs 2:45-51, 1978
77. Malberti F, Surian M, Farina M, et al: Effect of hemodialysis and hemodiafiltration on uremic neuropathy. Blood Purif 9:285-295, 1991
78. Eisenberg B, Murata G, Tzamaloukas A, et al: Gastroparesis in diabetics on chronic dialysis: Clinical and laboratory associations and predictive features. Nephron 70:296-300, 1995
79. Kingsley B, Gramm H, ROlla A: Diabetic gastroparesis: A review. J Diabetes Complications 5:207-217, 1991
80. Vincenti F, Arnaud S, Recker R, et al: Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25:677-682, 1984
81. Andress D, Kopp J, Maloney N, et al: Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 316:292-296, 1987
82. Ruggian J, Maesaka J, Fishbane S: Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis 28:409-414, 1996
83. Roe S, Graham L, Brock W, et al: Calciphylaxis: Early recognition and management. Am Surg 60:81-86, 1994
84. Herman D, Friedman E, Lundin A: Aggressive ophthalmological management in diabetic end-stage renal disease patients: A study of 31 consecutively referred patients. Am J Nephrol 12:344-350, 1992
85. Flynn H, Chew E, Simons B, et al: Pars plana vitree-tomy in the early treatment diabetic retinopathy study: ETDRS report number 17: The early treatment diabetic retinopathy study research group. Opthalmology 99:1351-1357, 1992
86. Mailloux L, Bellucci A, Napolitano B, et al: Death by withdrawal from dialysis: A 20 year clinical experience. J Am Soc Nephrol 3:1631-1637, 1993
87. Vlassara H: Serum Advanced glycosylation end products: A new class of uremic toxins? Blood Purif 12:54-59, 1994
88. Ritz E, Deppisch R, Nawroth P: Toxicity of uraemiadoes it come of AGE? Nephrol Dial Transplant 9:1-2, 1994
89. Takahashi M, Kushida K, Kawana K, et al: Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 39:2162-2165, 1993
90. Makita Z, Bucala R, Rayfield EJ, et al: Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet 343:1519-1522, 1994
91. Friedlander M, Wu Y, Schulak J, et al: Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 25:445-451, 1995
92. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
93. Wautier JL, Wautier MP, Schmidt AM, et al: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface associated AGEs and diabetic complications. Proc Natl Acad Sei USA 91:7742-7746, 1994
94. Kirstein M, Brett J, Radoff S, et al: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
95. Schmidt A, Yan S, Brett J, et al: Regulation of human mononuclear phagocyte migration by cell surface binding proteins for AGEs. J Clin Invest 91:2155-2168, 1993
96. Schmidt A, Hori O, Brett J, et al: Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the patho- genesis of vascular lesions. Arterioscler Thromb 14:1521-1528, 1994
97. Makita Z, Radoff S, Rayfield E, et al: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
98. Njoroge F, Monnier V: The chemistry of the Maillard reaction under physiological conditions: A review. Prog Clin Biol Res 304:85-107, 1989
99. Bucala R, Cerami A: Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23:1-34, 1992
100. Vishwanath V, Frank K, Elmets C, et al: Glycation of skin collagen in type I diabetes mellitus: Correlation with the long term complications. Diabetes 35:916-921, 1986
101. Monnier VM, Sell DR, Miyata S, et al: Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia: relevance to diabetic nephropathy. Acta Diabetol 29:130-135, 1992
102. Fu M-X, Wells-Knecht KJ, Blackledge JA, et al: Glycation, glycoxidation, and cross-linking of collagen by glucose. Diabetes 43:676-683, 1994
103. Sell D, Monnier V: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
104. Friedlander M, Wu Y, Elgawish A, et al: Early and advanced glycosylation end products: Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97:728-735, 1996
105. Hricik D, Schulak J, Sell D, et al: Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int 43:398-403, 1993
106. Hricik D, Wu Y, Schulak J, et al: Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 10:568-573, 1996
107. Friedman E: Potential of aminoguanidine in diabetic CAPD patients. Pent Dial Int 15:110-113, 1995
108. Hammes H, Martin S, Federlin K, et al: Aminoguandidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sei USA 88:11555-11558,1991